<DOC>
	<DOCNO>NCT00404131</DOCNO>
	<brief_summary>The purpose trial compare effectiveness safety INS365 Ophthalmic Solution placebo apply topically subject dry eye disease .</brief_summary>
	<brief_title>Study INS365 Ophthalmic Solution Subjects With Dry Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>best correct visual acuity eye least +0.7 sixmonth document history dry eye disease least mild severity 2 4 dry eye symptom unanesthetized Schirmer score less equal 7mm corneal fluorescein stain great equal 4 ( 15 ) nasally stimulate Schirmer score le 3mm subject initial Schirmer score 0mm ongoing contact lens wear current topical ophthalmic medication use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>